LAVA Therapeutics N.V. (LVTX) Tops Q1 EPS by 29c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q1 EPS of ($0.02), $0.29 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $6.99 million.

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• UBS cuts KOSPI target by nearly 10% to reflect higher rates
• UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'